Literature DB >> 19469635

Burden of hospitalization for gastrointestinal tract cancer patients - Results from a cross-sectional study in Tehran.

Mohamad Amin Pourhoseingholi1, Mohsen Vahedi, Bijan Moghimi-Dehkordi, Asma Pourhoseingholi, Fatemeh Ghafarnejad, Elham Maserat, Azadeh Safaee, Babak Khoshkrood Mansoori, Mohammad Reza Zali.   

Abstract

BACKGROUND: Cancer is the third most common cause of death in Iran. The gastrointestinal cancers are the most frequent neoplasms among Iranian males and second to breast cancer among females. The objective of this study was to provide accurate up-to-date epidemiological information of hospitalized patients with GI tract cancer in Iran.
METHODS: This study was designed as a retrospective cross-sectional survey included all consecutive GI cancer patients admitted over a one year period in a randomly selected hospital group located in metropolitan Tehran in 2006. Residence, age, sex, type of cancer and length of hospitalization were analyzed.
RESULTS: A total of 2,674 GI tract cancer patients were included in the study, There were 1,616 men (60.4%) and 1,058 women (39.6%). The majority of cancers were in the colorectum (40.0%), followed by the stomach (34.5%) and the esophagus (17.1%). The mean hospitalized durations were 7.5-/+6.5 days for men and 7.2-/+8.1 days for women. Male patients were significantly older than the women.
CONCLUSION: By considering the hospitalized GI tract cancers and majority cases of colorectal cancer, prevention programs like as CRC screening should be going on in order to reducing morbidity and incidence rates in a high-risk population for GI tract cancers.

Entities:  

Mesh:

Year:  2009        PMID: 19469635

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  18 in total

1.  Increased burden of colorectal cancer in Asia.

Authors:  Mohamad Amin Pourhoseingholi
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

2.  Colorectal cancer screening: Time for action in Iran.

Authors:  Mohamad Amin Pourhoseingholi; Mohammad Reza Zali
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

3.  Histopathologic Prolife of Primary Gastrointestinal Malignancies in Uyo City (Niger-Delta Region of Nigeria).

Authors:  Emmanuel K Abudu; Oluyinka S Akinbami
Journal:  Rare Tumors       Date:  2016-04-06

4.  Recurrence and Five -Year Survival in Colorectal Cancer Patients After Surgery.

Authors:  Seyed Reza Fatemi; Mohamad Amin Pourhoseingholi; Farshad Asadi; Mohsen Vahedi; Sara Pasha; Leila Alizadeh; Mohammad Reza Zali
Journal:  Iran J Cancer Prev       Date:  2015-08-24

5.  THE DISTRIBUTION, HISTOLOGIC PROFILE AND CLINICAL PRESENTATION OF GASTROINTESTINAL MALIGNANCIES IN LAGOS, NIGERIA.

Authors:  M Y Habeebu; O Salako; P T Okediji; B Mabadeje; O M Awofeso; A T Ajekigbe; F B Abdulkareem
Journal:  J West Afr Coll Surg       Date:  2017 Jan-Mar

6.  Evaluation of parametric models by the prediction error in colorectal cancer survival analysis.

Authors:  Ahmad Reza Baghestani; Mahmood Reza Gohari; Arezoo Orooji; Mohamad Amin Pourhoseingholi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

7.  Mortality trends of gastrointestinal cancers in Iranian population.

Authors:  Mohamad Amin Pourhoseingholi; Zeinab Fazeli; Sara Ashtari; Fatemeh Sadat Fazeli Bavand-Pour
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

8.  Bayesian correction for mortality trend of oral cavity cancer.

Authors:  Mohamad Amin Pourhoseingholi; Mohsen Vahedi; Ahmad Reza Baghestani; Alireza Abadi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012

9.  Specific count model for investing the related factors of cost of GERD and functional dyspepsia.

Authors:  Alireza Abadi; Asma Pourhoseingholi; Samira Chaibakhsh; Azadeh Safaee; Bijan Moghimi-Dehkordi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

10.  Iranian regional cancer incidence is misclassified in neighborhood's provinces.

Authors:  Mohamad Amin Pourhoseingholi; Ahmadreza Baghestani; Alireza Abadi; Nastaran Hajizadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.